Predictive models of type 1 diabetes progression: Understanding T-cell cycles and their implications on autoantibody release

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Jaberi Douraki, Majid ^a   Pietropaolo, Massimo ^b   Khadra, Anmar ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; T LYMPHOCYTE RECEPTOR;

ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; CELL CYCLE; CELL KILLING; DISEASE DURATION; HIGH RISK POPULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE ACTIVATION; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; POPULATION MODEL; RELAPSE; REMISSION; T LYMPHOCYTE; CELL CLONE; CYTOTOXICITY; DIABETES MELLITUS, TYPE 1; DISEASE COURSE; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PROGNOSIS; RECURRENT DISEASE; THEORETICAL MODEL;

AUTOANTIBODIES; B-LYMPHOCYTES; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; HUMANS; MODELS, THEORETICAL; PROGNOSIS; RECURRENCE; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTES;

EID: 84899421060     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093326     Document Type: Article

References (54)

1. Atkinson MA, Eisenbarth GS (2001) Type 1 diabetes: new perspectives on disease pathogenesis and treatment. The Lancet 358: 221-229. (Pubitemid 32718550)
2. Nelson P, Smith N, Ciupe S, Zou W, Omenn GS, et al. (2009) Modeling dynamic changes in type 1 diabetes progression: quantifying beta-cell variation after the appearance of islet-specific autoimmune responses. Mathematical biosciences and engineering: MBE 6: 753-778.
3. Peakman M, Stevens EJ, Lohmann T, Narendran P, Dromey J, et al. (1999) Naturally processed and presented epitopes of the islet cell autoantigen ia-2 eluted from hla-dr4. Journal of Clinical Investigation 104: 1449-1457.
4. Liu Y, Wenzlau J, Yu L, Patel C, Eisenbarth G, et al. (2008) Conserved epitopes in the protein tyrosine phosphatase family of diabetes autoantigens. Annals of the New York Academy of Sciences 1150: 245-247.
5. Morran MP, Casu A, Arena VC, Pietropaolo S, Zhang YJ, et al. (2010) Humoral autoimmunity against the extracellular domain of the neuroendocrine autoantigen ia-2 heightens the risk of type 1 diabetes. Endocrinology 151: 2528-2537.
6. Morran MP, Omenn GS, Pietropaolo M (2008) Immunology and genetics of type 1 diabetes. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 75: 314-327.
7. Jacob J, Baltimore D (1999) Modelling t-cell memory by genetic marking of memory t cells in vivo. Nature 399: 593-597.
8. Savage PA, Boniface JJ, Davis MM (1999) A kinetic basis for t cell receptor repertoire selection during an immune response. Immunity 10: 485-492. (Pubitemid 29205484)
9. Valitutti S, Müller S, Cella M, Padovan E, Lanzavecchia A (1995) Serial triggering of many t-cell receptors by a few peptide mhc complexes. Nature 375: 148-151.
10. Veiga-Fernandes H, Walter U, Bourgeois C, McLean A, Rocha B (2000) Response of naive and memory cd8+ t cells to antigen stimulation in vivo. Nature immunology 1: 47-53.
11. Viola A, Lanzavecchia A (1996) T cell activation determined by t cell receptor number and tunable thresholds. Science 273: 104-106. (Pubitemid 26255435)
12. Wells A, Gudmundsdottir H, Turka L (1997) Following the fate of individual t cells throughout activation and clonal expansion. signals from t cell receptor and cd28 differentially regulate the induction and duration of a proliferative response. Journal of Clinical Investigation 100: 3173.
13. Margulies DH (1997) Interactions of tcrs with mhc-peptide complexes: a quantitative basis for mechanistic models. Current opinion in immunology 9: 390-395.
14. Miao D, Yu L, Eisenbarth GS (2007) Role of autoantibodies in type 1 diabetes. Front Biosci 12: 1889-1898. (Pubitemid 46846814)
15. James EA, LaFond R, Durinovic-Bello I, Kwok W (2009) Visualizing antigen specific cd4+ t cells using mhc class ii tetramers. Journal of visualized experiments: JoVE.
16. Oling V, Marttila J, Ilonen J, Kwok WW, Nepom G, et al. (2005) Gad65- and proinsulin-specific cd4+ t-cells detected by fMHCg class fIIg tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects. Journal of Autoimmunity 25: 235-243. (Pubitemid 41654469)
17. Reijonen H, Novak EJ, Kochik S, Heninger A, Liu AW, et al. (2002) Detection of gad65-specific t-cells by major histocompatibility complex class ii tetramers in type 1 diabetic patients and at-risk subjects. Diabetes 51: 1375-1382. (Pubitemid 34826602)
18. Standifer NE, Ouyang Q, Panagiotopoulos C, Verchere CB, Tan R, et al. (2006) Identification of novel hla-a*0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives. Diabetes 55: 3061-3067. (Pubitemid 44923643)
19. Velthuis JH, Unger WW, Abreu JR, Duinkerken G, Franken K, et al. (2010) Simultaneous detection of circulating autoreactive cd8+ t-cells specific for different islet cell-associated epitopes using combinatorial mhc multimers. Diabetes 59: 1721-1730.
20. Janeway CA, Travers P, Walport M, Shlomchik MJ (2005) Immunobiology: the immune system in health and disease.
21. Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E (1995) Identification of protein tyrosine phosphatase-like ia2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40k autoantigen and a target of islet-cell antibodies. The Journal of Immunology 155: 5419-5426.
22. Borg H, Fernlund P, Sundkvist G (1997) Protein tyrosine phosphatase-like protein ia2-antibodies plus glutamic acid decarboxylase 65 antibodies (gada) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus. Clinical chemistry 43: 2358-2363. (Pubitemid 28022973)
23. DeNiro M, Al-Mohanna FA (2012) Zinc transporter 8 (znt8) expression is reduced by ischemic insults: a potential therapeutic target to prevent ischemic retinopathy. PloS one 7: e50360.
24. Hawa M, Rowe R, Lan MS, Notkins AL, Pozzilli P, et al. (1997) Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes. Diabetes 46: 1270-1275. (Pubitemid 27315274)
25. Kawasaki E (2012) Znt8 and type 1 diabetes. Endocrine journal 59: 531-537.
26. Peakman M, Tree TI, Endl J, van Endert P, Atkinson MA, et al. (2001) Characterization of preparations of gad65, proinsulin, and the islet tyrosine phosphatase ia-2 for use in detection of autoreactive t-cells in type 1 diabetes report of phase ii of the second international immunology of diabetes society workshop for standardization of t-cell assays in type 1 diabetes. Diabetes 50: 1749-1754. (Pubitemid 33641592)
27. Pietropaolo M, Barinas-Mitchell E, Kuller LH (2007) The heterogeneity of diabetes unraveling a dispute: Is systemic inammation related to islet autoimmunity? Diabetes 56: 1189-1197. (Pubitemid 46722429)
28. Pietropaolo M, Becker D, LaPorte R, Dorman J, Riboni S, et al. (2002) Progression to insulinrequiring diabetes in seronegative prediabetic subjects: the role of two hla-dq high-risk haplotypes. Diabetologia 45: 66-76. (Pubitemid 34118544)
29. Pietropaolo M, Surhigh JM, Nelson PW, Eisenbarth GS (2008) Primer: immunity and autoimmunity. Diabetes 57: 2872-2882.
30. Uibo R, Lernmark Å (2008) Gad65 autoimmunityclinical studies. Advances in immunology 100: 39-78.
31. Wenzlau JM, Moua O, Sarkar SA, Yu L, Rewers M, et al. (2008) Slc30a8 is a major target of humoral autoimmunity in type 1 diabetes and a predictive marker in prediabetes. Annals of the New York Academy of Sciences 1150: 256-259.
32. Pietropaolo M, Towns R, Eisenbarth GS (2012) Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes. Cold Spring Harbor perspectives in medicine: a012831.
33. Bluestone JA, Herold K, Eisenbarth G (2010) Genetics, pathogenesis and clinical interventions in type [thinsp] 1 diabetes. Nature 464: 1293-1300.
34. Khadra A, Pietropaolo M, Nepom GT, Sherman A (2011) Investigating the role of t-cell avidity and killing efficacy in relation to type 1 diabetes prediction. PloS one 6: e14796.
35. Mallone R, Kochik SA, Reijonen H, Carson B, Ziegler SF, et al. (2005) Functional avidity directs t-cell fate in autoreactive cd4+ t cells. Blood 106: 2798-2805. (Pubitemid 41510756)
36. von Herrath M, Sanda S, Herold K (2007) Type 1 diabetes as a relapsing-remitting disease? Nature Reviews Immunology 7: 988-994. (Pubitemid 350166057)
37. Trudeau JD, Kelly-Smith C, Verchere CB, Elliott JF, Dutz JP, et al. (2003) Prediction of spontaneous autoimmune diabetes in nod mice by quantification of autoreactive t cells in peripheral blood. Journal of Clinical Investigation 111: 217-223. (Pubitemid 36105920)
38. Mahaffy JM, Edelstein-Keshet L (2007) Modeling cyclic waves of circulating t cells in autoimmune diabetes. SIAM Journal on Applied Mathematics 67: 915-937. (Pubitemid 47317911)
39. Vendrame F, Pileggi A, Laughlin E, Allende G, Martin-Pagola A, et al. (2010) Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive cd4 t-cells. Diabetes 59: 947-957.
40. Marée AF, Santamaria P, Edelstein-Keshet L (2006) Modeling competition among autoreactive cd8 + t cells in autoimmune diabetes: implications for antigen-specific therapy. International immunology 18: 1067-1077. (Pubitemid 43923425)
41. Finegood DT, Scaglia L, Bonner-Weir S (1995) Dynamics of β-cell mass in the growing rat pancreas: estimation with a simple mathematical model. Diabetes 44: 249-256.
42. Skowera A, Ellis RJ, Varela-Calviño R, Arif S, Huang GC, et al. (2008) Ctls are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. The Journal of clinical investigation 118: 3390.
43. Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, et al. (2007) Activation-induced foxp3 in human t effector cells does not suppress proliferation or cytokine production. International immunology 19: 345-354. (Pubitemid 46523383)
44. Lejeune O, Chaplain MA, El Akili I (2008) Oscillations and bistability in the dynamics of cytotoxic reactions mediated by the response of immune cells to solid tumours. Mathematical and Computer Modelling 47: 649-662. (Pubitemid 351210695)
45. Alexander H, Wahl L (2011) Self-tolerance and autoimmunity in a regulatory t cell model. Bulletin of mathematical biology 73: 33-71.
46. Arazi A, Neumann A (2010) Modeling immune complex-mediated autoimmune inammation. Journal of theoretical biology 267: 426-436.
47. Arazi A, Pendergraft WF III, Ribeiro RM, Perelson AS, Hacohen N (2013) Human systems immunology: Hypothesis-based modeling and unbiased data-driven approaches. In: Seminars in immunology. Elsevier, volume 25, pp. 193-200.
48. Borghans JA, Taams LS, Wauben MH, De Boer RJ (1999) Competition for antigenic sites during t cell proliferation: a mathematical interpretation of in vitro data. Proceedings of the National Academy of Sciences 96: 10782-10787. (Pubitemid 29442221)
49. Delitala M, Dianzani U, Lorenzi T, Melensi M (2013) A mathematical model for immune and autoimmune response mediated by t-cells. Computers & Mathematics with Applications 66: 1010-1023.
50. Khadra A, Santamaria S, Edelstein-Keshet L (2009) The role of low avidity t cells in the protection against type 1 diabetes: A modeling investigation. Journal of Theoretical Biology 256: 126-141.
51. Parham P (2009) The immune system. Garland Science, 3d edition. 608p.
52. Pescovitz M, Greenbaum C, Krause-Steinrauf H, Becker D, Gitelman S, et al. (2009) Rituximab, b - lymphocyte depletion, and preservation of β-cell function. The New England Journal of Medicine 361: 2143-2152.
53. Galea I, Stasakova J, Dunscombe M, Ottensmeier C, Elliott T, et al. (2012) Tcell cross-competition is governed by peptide-mhc class i stability. European Journal of Immunology 42: 256-63.
54. Scherer A, Salathé M, Bonhoeffer S (2006) High epitope expression levels increase competition between t cells. PLoS Comput Biol 2: 1-11.